BioCentury
ARTICLE | Finance

Quark’s global ambitions

How Quark, GF Securities plan to deploy their $500M life sciences fund

October 31, 2016 7:00 AM UTC

After getting its toes wet with a couple of biotech seed investments and hiring a drug development veteran as partner and CEO, Canadian VC Quark Venture Inc. teamed up with GF Securities Co. Ltd. (SZSE:000776; HKSE:1776) to raise and manage a $500 million fund.

The partners closed the first $100 million of the Global Health Sciences Venture Fund on Oct. 17 and plan to announce six investments by year end...

BCIQ Company Profiles

MSI Methylation Sciences Inc.